Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

BioSeeker: Built for the Speed of Disease

A Modular Platform forPrecision Response

BioSeeker™, PTAP™ Therapeutics, and SeekIt™ Diagnostics work together to respond to emerging pathogens with programmable speed–from intelligence to treatment to detection.

The Discovery Engine
Our AI discovery engine, BioSeeker™, powers every step of Seek Labs’ innovation—from decoding high-impact genetic targets to designing rapid, field-ready diagnostics and programmable therapeutics. It’s the intelligence layer behind both platforms—driving faster timelines, smarter decisions, and precision at global scale.
Programmable CRISPR-Based Therapeutics
A new class of precision medicines engineered to irreversibly disable disease at the genomic level. Powered by BioSeeker™ and built on Seek Labs’ PTAP™ platform, these therapeutics are designed to target and ablate the exact sequences pathogens need to replicate and spread—delivering fast, adaptable interventions for the world’s most urgent threats.
Molecular Testing at the Point of Care
A fully self-contained diagnostic platform that brings lab-grade molecular testing directly to patients—no instruments, no power, no infrastructure required. Designed in conjunction with BioSeeker™ for real-world impact, SeekIt™ delivers fast, accurate results wherever they’re needed most—from homes and clinics to farms, field labs, and outbreak zones.

Disease moves faster than most systems can respond — faster than diagnostics, faster than therapeutics, and faster than global coordination. Seek Labs was founded to close that gap with technology designed to accelerate discovery, compress timelines, and respond at the speed of outbreak.

We believe the response should be programmable. Precision should be scalable. And health innovation should reach the people who need it most, faster.

Because un

Built. Tested. Scaling.

Global Therapeutic Atlas

BioSeeker has built an adaptive genomic map that reveals the most vulnerable points in evolving diseases. The Global Therapeutic Atlas guides the rapid development of programmable therapeutics to strike before disease spreads.

The power of the platform

Boldly Seeking a Healthier World

When new diseases hit, science scrambles. But what if we didn’t have to wait? What if precision treatments and diagnostics could be built before diseases spread? Our platforms are built with purpose, tested in real-world settings, and actively scaling toward global deployment. 

At Seek Labs, we don’t wait for change; we build it.

We’re actively engaging with partners across diagnostics, therapeutics, global health, and pandemic preparedness. If you’re building toward faster responses, more accessible innovation, and globally scalable tools — let’s connect.

Back to top Drag